Detalhe da pesquisa
1.
R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203.
Br J Haematol
; 204(3): 849-860, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37996986
2.
Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.
Hematol Oncol
; 42(3): e3272, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38595316
3.
Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma.
Hematol Oncol
; 40(4): 667-677, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35142384
4.
Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy.
Cancer Sci
; 112(5): 1943-1954, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33576088
5.
Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1).
Jpn J Clin Oncol
; 51(7): 1059-1066, 2021 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33959770
6.
Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin.
Ann Hematol
; 98(7): 1647-1655, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31001658
7.
Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.
Cancer Sci
; 109(6): 2056-2062, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29601137
8.
Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant-ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105.
Hematol Oncol
; 41(3): 590-593, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36416678
9.
Prognostic biomarkers in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.
Cancer Sci
; 105(11): 1435-41, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25181936
10.
Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.
Cancer Sci
; 101(9): 2059-64, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20626754
11.
Radiotherapy for localized gastric mucosa-associated lymphoid tissue lymphoma: long-term outcomes over 10 years.
J Radiat Res
; 58(4): 537-542, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28077625
12.
Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan.
J Clin Oncol
; 35(1): 32-39, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28034070
13.
EBV-positive Burkitt lymphoma as a late-onset posttransplantion lymphoproliferative disorder after allogeneic stem cell transplantation.
Int J Hematol
; 79(4): 387-9, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15218971